BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 34001062)

  • 1. KDM6B promotes ESCC cell proliferation and metastasis by facilitating C/EBPβ transcription.
    Qin M; Han F; Wu J; Gao FX; Li Y; Yan DX; He XM; Long Y; Tang XP; Ren DL; Gao Y; Dai TY
    BMC Cancer; 2021 May; 21(1):559. PubMed ID: 34001062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KDM6B-mediated histone demethylation of LDHA promotes lung metastasis of osteosarcoma.
    Jiang Y; Li F; Gao B; Ma M; Chen M; Wu Y; Zhang W; Sun Y; Liu S; Shen H
    Theranostics; 2021; 11(8):3868-3881. PubMed ID: 33664867
    [No Abstract]   [Full Text] [Related]  

  • 3. JmjC-KDMs KDM3A and KDM6B modulate radioresistance under hypoxic conditions in esophageal squamous cell carcinoma.
    Macedo-Silva C; Miranda-Gonçalves V; Lameirinhas A; Lencart J; Pereira A; Lobo J; Guimarães R; Martins AT; Henrique R; Bravo I; Jerónimo C
    Cell Death Dis; 2020 Dec; 11(12):1068. PubMed ID: 33318475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic potential of GSK-J4, a histone demethylase KDM6B/JMJD3 inhibitor, for acute myeloid leukemia.
    Li Y; Zhang M; Sheng M; Zhang P; Chen Z; Xing W; Bai J; Cheng T; Yang FC; Zhou Y
    J Cancer Res Clin Oncol; 2018 Jun; 144(6):1065-1077. PubMed ID: 29594337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting P16INK4A in uterine serous carcinoma through inhibition of histone demethylation.
    Xiao Z; He Y; Liu C; Xiang L; Yi J; Wang M; Shen T; Shen L; Xue Y; Shi H; Liu P
    Oncol Rep; 2019 May; 41(5):2667-2678. PubMed ID: 30896884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CCAAT/Enhancer Binding Protein β-Mediated MMP3 Upregulation Promotes Esophageal Squamous Cell Cancer Invasion
    Li H; Yang F; Chai L; Zhang L; Li S; Xu Z; Kong L
    Genet Test Mol Biomarkers; 2019 May; 23(5):304-309. PubMed ID: 30969151
    [No Abstract]   [Full Text] [Related]  

  • 7. BACH1 promotes the progression of esophageal squamous cell carcinoma by inducing the epithelial-mesenchymal transition and angiogenesis.
    Zhao Y; Gao J; Xie X; Nan P; Liu F; Sun Y; Zhao X
    Cancer Med; 2021 May; 10(10):3413-3426. PubMed ID: 33932125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TP63, SOX2, and KLF5 Establish a Core Regulatory Circuitry That Controls Epigenetic and Transcription Patterns in Esophageal Squamous Cell Carcinoma Cell Lines.
    Jiang YY; Jiang Y; Li CQ; Zhang Y; Dakle P; Kaur H; Deng JW; Lin RY; Han L; Xie JJ; Yan Y; Doan N; Zheng Y; Mayakonda A; Hazawa M; Xu L; Li Y; Aswad L; Jeitany M; Kanojia D; Guan XY; Said JW; Yang W; Fullwood MJ; Lin DC; Koeffler HP
    Gastroenterology; 2020 Oct; 159(4):1311-1327.e19. PubMed ID: 32619460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PURα mediates epithelial-mesenchymal transition to promote esophageal squamous cell carcinoma progression by regulating Snail2.
    Gao J; Tian L; Sun Y; Li W; Zhao L; Sun Y; Jing Z; Zhou L; Liu F; Zhao X
    Cancer Lett; 2021 Feb; 498():98-110. PubMed ID: 33144099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long noncoding RNA SNHG12 induces proliferation, migration, epithelial-mesenchymal transition, and stemness of esophageal squamous cell carcinoma cells via post-transcriptional regulation of BMI1 and CTNNB1.
    Wu D; He X; Wang W; Hu X; Wang K; Wang M
    Mol Oncol; 2020 Sep; 14(9):2332-2351. PubMed ID: 32239639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ATAD2 interacts with C/EBPβ to promote esophageal squamous cell carcinoma metastasis via TGF-β1/Smad3 signaling.
    Cao LJ; Zhang YJ; Dong SQ; Li XZ; Tong XT; Chen D; Wu ZY; Zheng XH; Xue WQ; Jia WH; Zhang JB
    J Exp Clin Cancer Res; 2021 Mar; 40(1):109. PubMed ID: 33757572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SNHG5 inhibits the progression of EMT through the ubiquitin-degradation of MTA2 in oesophageal cancer.
    Wei S; Sun S; Zhou X; Zhang C; Li X; Dai S; Wang Y; Zhao L; Shan B
    Carcinogenesis; 2021 Feb; 42(2):315-326. PubMed ID: 33095847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of Hippo/YAP signaling and Esophageal Squamous Carcinoma progression by an E3 ubiquitin ligase PARK2.
    Zhou X; Li Y; Wang W; Wang S; Hou J; Zhang A; Lv B; Gao C; Yan Z; Pang D; Lu K; Ahmad NH; Wang L; Zhu J; Zhang L; Zhuang T; Li X
    Theranostics; 2020; 10(21):9443-9457. PubMed ID: 32863938
    [No Abstract]   [Full Text] [Related]  

  • 14. TGF-β-induced PLEK2 promotes metastasis and chemoresistance in oesophageal squamous cell carcinoma by regulating LCN2.
    Wang F; Zhang C; Cheng H; Liu C; Lu Z; Zheng S; Wang S; Sun N; He J
    Cell Death Dis; 2021 Oct; 12(10):901. PubMed ID: 34601488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histone demethylase KDM6B regulates human podocyte differentiation
    Guo Y; Xiong Z; Guo X
    Biochem J; 2019 Jun; 476(12):1741-1751. PubMed ID: 31138771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circular RNA hsa_circ_0000654 promotes esophageal squamous cell carcinoma progression by regulating the miR-149-5p/IL-6/STAT3 pathway.
    Xu Z; Tie X; Li N; Yi Z; Shen F; Zhang Y
    IUBMB Life; 2020 Mar; 72(3):426-439. PubMed ID: 31778020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of histone demethylase KDM6B enhances aggressiveness of pancreatic cancer through downregulation of C/EBPα.
    Yamamoto K; Tateishi K; Kudo Y; Sato T; Yamamoto S; Miyabayashi K; Matsusaka K; Asaoka Y; Ijichi H; Hirata Y; Otsuka M; Nakai Y; Isayama H; Ikenoue T; Kurokawa M; Fukayama M; Kokudo N; Omata M; Koike K
    Carcinogenesis; 2014 Nov; 35(11):2404-14. PubMed ID: 24947179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KDM6B is an androgen regulated gene and plays oncogenic roles by demethylating H3K27me3 at cyclin D1 promoter in prostate cancer.
    Cao Z; Shi X; Tian F; Fang Y; Wu JB; Mrdenovic S; Nian X; Ji J; Xu H; Kong C; Xu Y; Chen X; Huang Y; Wei X; Yu Y; Yang B; Chung LWK; Wang F
    Cell Death Dis; 2021 Jan; 12(1):2. PubMed ID: 33414463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lysine Demethylase 6B Regulates Prostate Cancer Cell Proliferation by Controlling c-MYC Expression.
    Yıldırım-Buharalıoğlu G
    Mol Pharmacol; 2022 Feb; 101(2):106-119. PubMed ID: 34862309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. lncRNA PART1, manipulated by transcriptional factor FOXP2, suppresses proliferation and invasion in ESCC by regulating the miR‑18a‑5p/SOX6 signaling axis.
    Zhao Y; Zhang Q; Liu H; Wang N; Zhang X; Yang S
    Oncol Rep; 2021 Mar; 45(3):1118-1132. PubMed ID: 33432363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.